Anda Biopharmaceutical Development (shenzhen) Co., Ltd.

This program offers a personalized peptide vaccine, PCNAT-01, to eligible patients with pancreatic cancer who have had surgery and completed chemotherapy. The vaccine is designed to train the immune system to recognize and attack leftover cancer cells, potentially lowering the ch…